Recurrent surgery in device patients carries a certain risk of infection and should therefore be kept to a minimum. We present the case of a patient in 
Case presentation
In 1991, a 65-year-old male patient was implanted with a dual chamber pacemaker for symptomatic persistent third degree atrioventricular block. Both leads were inserted via the right cephalic vein. Elective device replacement was first necessary in 2000. In 2007, the battery was depleted again. As an insulation defect of the atrial lead was present, lead replacement was planned at the same time. During surgery, the subclavian vein was found to be occluded, resulting in the implantation of a new atrial lead via the right internal jugular vein. In March 2015, the pacemaker battery was once more depleted. As the right ventricular lead now showed a slow, but continuous decrease in impedance 
Pacemaker problem
The pertinent question was whether the right-sided pacemaker should be left in place and programmed to an ODO or OOO mode, or if it should be explanted.
Arguments against explanting the pacemaker were that there was no obvious clinical need and that there is a statistical 1.4% chance of infection [1] , double that associated with a de-novo implant [2] . This had to be 
Biotronik pacemakers
The pacemaker can be programmed to an "off" mode.
However, a password given by the manufacturer's representative is needed to program this mode. At ERI, this "off" mode is not changed. Programming is only reverted if a back-up mode event occurs, e.g., due to heavy electromagnetic interference, or at "end of life". However, at EOL pacing output is already so low that no effective pacing occurs. This behaviour applies to pacemakers of all generations as well as to cardiac resynchronisation therapy (CRT) devices.
The pacemaker thus does not need to be explanted.
Boston Scientific pacemakers
Pacing can be programmed "off". This mode is not affect ed by EOL. During further depletion, the pacemaker will switch to a storage mode and then cannot pace any longer. This behaviour applies to pacemakers of all generations as well as to CRT devices.
Medtronic pacemakers
At ERI, programming will switch to VVI 65/min with an output of 5.0 V / 1.0 ms. At EOL, the device typically continues to work in VVI 65/min. Sometimes beyond EOL (and there is no way to tell when) there is a moment when the device can reset ("power on reset") owing to low battery voltage, and resume pacing at random settings and device behaviour. This behaviour applies to pacemakers of all generations as well as to CRT devices.
The pacemaker thus needs to be explanted.
Sorin (LivaNova) pacemakers
If the battery impedance falls below the ERI value, the device switches to VVI 70/min with unipolar pacing of 5.0 V / 0.5 ms, whatever the previous programmed mode was. Sensing is set to 2.2 mV in a unipolar mode.
Even if a OOO mode were reprogrammed, the next day the device will again perform an impedance measurement and switch back to VVI 70/min. This interferes with standard settings, especially in patients with DDD pacemakers. This behaviour applies to pacemakers of all generations as well as to CRT devices.
The pacemaker thus usually needs to be explanted.
St Jude Medical pacemakers
The programmed pacemaker mode is not affected and remains in the ODO/OVO setting. However, if the pacemaker falls into "back-up" mode, it switches into a VVI mode. Such a switch occurs when the pacemaker notices inconsistencies in its software status. In spite of this being a rare phenomenon, St Jude Medical recommends explanting the pacemaker.
Conclusion
In our patient, the Medtronic pacemaker was explant ed. Over a follow-up of 9 months, the course of the patient was uneventful.
Generally, it depends on the specific behaviour of the pacemakers from each manufacturer whether a pacemaker must be explanted or not in such a situation.
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